Renhowe, Paul Allan,Ge, Pei,Masferrer, Jaime L.,Im, G-Yoon Jamie,Currie, Mark G.,Sheppeck, James Edward
申请号：
AU2017216429
公开号：
AU2017216429A1
申请日:
2017.01.31
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present disclosure relates to methods, uses, pharmaceutical compositions and kits comprising an sGC stimulator or a pharmaceutically acceptable salt thereof, alone or in combination with one or more additional therapeutic agents, for the treatment of Nonalcoholic Steatohepatitis (NASH).
